Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/6/2026 | 707 | 0.0% | 14,227 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 744 | 0.0% | 15,558 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 500 | 0.0% | 15,871 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 527 | 0.0% | 16,097 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 556 | 0.0% | 15,371 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 491 | 0.0% | 15,733 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 458 | 0.0% | 17,110 | 6/30/2024 |
| 2024 Q1 | 5/10/2024 | 682 | 0.0% | 19,983 | 3/31/2024 |
| 2023 Q4 | 3/22/2024 | 642 | 0.0% | 22,188 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 605 | 0.0% | 21,942 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 764 | 0.0% | 25,409 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 928 | 0.0% | 25,609 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 915 | 0.0% | 25,659 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 1,048 | 0.0% | 30,986 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 932 | 0.0% | 32,232 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 1,009 | 0.0% | 31,230 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 940 | 0.0% | 32,289 | 12/31/2021 |
| 2021 Q3 | 11/5/2021 | 642 | 0.0% | 24,083 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 680 | 0.0% | 22,099 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 520 | 0.0% | 19,877 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 222 | 0.0% | 8,823 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 170 | 0.0% | 8,145 | 9/30/2020 |
| 2020 Q2 | 8/28/2020 | 155 | 0.0% | 6,540 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 33 | 0.0% | 1,865 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 67 | 0.0% | 2,828 | 12/31/2019 |